Dr. Filip Janku is the Chief Medical Officer of Monte Rosa Therapeutics. Previously, he served as an Associate Professor of Investigational Cancer Therapeutics and Medical Director of the Clinical and Translational Research Center at MD Anderson Cancer Center. His experience includes many years in early-stage development of new cancer treatments with a focus on proof-of-concept studies of personalized cancer therapies. He has received multiple awards for his research efforts, including the Sabin Family Fellow Award, the Sidney Kimmel Scholar award, Khalifa Scholar Award, several ASCO Merit Awards and an American Association for Cancer Research Scholar-in-Training Award. He is the coauthor of more than 250 scientific articles that have appeared in peer-reviewed journals.
Dr. Janku earned his Ph.D. in Pathobiochemistry and his M.D. from Charles University in Prague. He completed his medical training at Charles University and The University of Texas MD Anderson Cancer Center.